Topics
Glioblastoma | Diagnosis | Magnetic resonance imaging | Differentiation between tumors
Home > Publications > Topics > Glioblastoma > Diagnosis > Magnetic resonance imaging > Differentiation between tumors
Kikuchi K, Togao O, Yamashita K, Momosaka D, Kikuchi Y, Kuga D,
Yuhei S, Fujioka Y, Narutomi F, Obara M, Yoshimoto K, Ishigami
K.
Comparison of diagnostic performance
of radiologist- and AI-based assessments of T2-FLAIR mismatch sign
and quantitative assessment using synthetic MRI in the
differential diagnosis between astrocytoma, IDH-mutant and
oligodendroglioma, IDH-mutant and
1p/19q-codeleted.
Neuroradiology.
2024 Jan 15. doi:
10.1007/s00234-024-03288-0. PMID:
38224343. Observational study. ˍ
Low JCM, Cao J, Hesse F, Wright AJ, Tsyben A, Alshamleh I, Mair R,
Brindle KM.
Deuterium metabolic imaging
differentiates glioblastoma metabolic subtypes and detects early
response to chemoradiotherapy.
Cancer
Res. 2024 Apr 18. doi:
10.1158/0008-5472.CAN-23-2552. PMID:
38635885. Laboratory investigation.
ˍ
Differentiation between glioblastoma, primary CNS lymphoma and metastasis
Chuthip
P, Sitthinamsuwan B, Witthiwej T, Tansirisithikul C, Khumpalikit
I, Nunta-Aree S.
Predictors
for the Differentiation between Glioblastoma, Primary Central
Nervous System Lymphoma, and Metastasis in Patients with a
Solitary Enhancing Intracranial Mass.
Asian
J Neurosurg.
2024 Jun 6;19(2):186-201. doi:
10.1055/s-0044-1787051. PMID:
38974428. Observational study. ˍ
Differentiation between glioblastoma and primary CNS lymphoma
Zhang Y, Luo X, Zhu Y, Zhang Q, Liu B.
Differentiation
between primary central nervous system lymphomas and gliomas
according to pharmacokinetic parameters derived from dynamic
contrast-enhanced magnetic resonance imaging.
Heliyon.
2024 Jun 6;10(12):e32619. doi:
10.1016/j.heliyon.2024.e32619. PMID:
38952379.
Observational study. ˍ
Differentiation between glioblastoma and primary CNS lymphoma
Würtemberger
U, Diebold M, Rau A, Akgün V, Becker L, Beck J, Reinacher PC,
Taschner CA, Reisert M, Fehrenbacher L, Erny D, Scherer F,
Hohenhaus M, Urbach H, Demerath T.
Advanced
diffusion imaging reveals microstructural characteristics of
primary CNS lymphoma, allowing differentiation from glioblastoma.
Neurooncol
Adv.
2024 Jun 8;6(1):vdae093. doi:
10.1093/noajnl/vdae093. PMID:
38946879. Observational study. ˍ
Differentiation between glioblastoma and primary CNS lymphoma
Chen Z, Liu H, Yang A, Liao J, Wu Z, Chen J, Miao W.
68Ga-Pentixafor PET in Combination
With MRI Improves the Differential Diagnosis of Glioblastoma and
Primary Central Nervous System Lymphoma.
Clin
Nucl Med. 2025 Jan 6. doi:
10.1097/RLU.0000000000005657. PMID:
39761437. Observational study˰
ˍ
Differentiating glioblastomas from adult diffuse gliomas
Zhang HW, Deng HZ, Feng YN, Tang XM, Su RR, Ouyang Y, Lin F, Wang
YL, Lei Y, Huang B.
Evaluating the
efficacy of advanced imaging techniques in differentiating
histological and molecular glioblastomas from adult diffuse
gliomas: PWI, DWI, and MRS.
Acta
Radiol. 2025 May 1:2841851251333328. doi:
10.1177/02841851251333328. PMID:
40313055.
Observational study˰ ˍ
Vankan B, Var V, Rommers N, Psychogios MN, Todea RA.
Treatment
response assessment in glioblastoma with GRASP DCE-MRI.
Eur
J Radiol. 2025 Jun 13;190:112234. doi:
10.1016/j.ejrad.2025.112234. PMID:
40543285.
Observational study. ˍ
AI
Overview
Gry
HS, Falk Delgado A.
Differentiation
of Molecular Glioblastomas and Lower-grade Diffuse Astrocytomas
Using MRI Perfusion and Diffusion Parameters.
Clin
Neuroradiol.
2025 Aug 20. doi:
10.1007/s00062-025-01550-3. PMID:
40833458. Observational study˰ ˍ